User menu

A single arm, multicenter, open-label phase II study of orally administered GW572016 as single-agent, second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract. Interim analysis. : Abstract #4615

Bibliographic reference Machiels, Jean-Pascal ; Wülfing, C. ; Richel, D.J. ; Beuzeboc, P. ; Garcia Del Muro, X. ; et. al. A single arm, multicenter, open-label phase II study of orally administered GW572016 as single-agent, second-line treatment of patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract. Interim analysis. : Abstract #4615.40th Annual Meeting of the American-Society-of-Clinical-Oncology ((United-States) New Orleans, Louisiana, du 05/06/2004 au 08/06/2004). In: Journal of Clinical Oncology, Vol. 22, no. 14, p. 410S (2004)
Permanent URL http://hdl.handle.net/2078.1/61077